Clinical Trial Update: A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for mavacamten in symptomatic obstructive hypertrophic cardiomyopathy; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cardiomyopathy, Hypertrophic | Phase 4 | Status: ACTIVE_NOT_RECRUITING